GET THE APP

Pharmaceutical Regulatory Affairs High Impact | Open Access Journals

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Submit Manuscript

Pharmaceutical Regulatory Affairs High Impact

Pharmaceutical Regulatory Affairs Journalhttps://urologistmeeting.healthconferences.org/ is one of the High Impact journals in Regulatory Affairs and related fields. The mission of Regulatory Affairs uses provides a forum for publishing new findings on Regulatory Affairs and related fields. Currently, our primary research objective is to encourage and assist the development of better and faster measures of scientific activity. In cases where we believe we can contribute directly, as opposed to highlighting the work of others, we are producing our own measures of scientific activity. Pharmaceutical Regulatory Affairs is a journal dedicated to producing analysis, insight, and data relating to questions of importance in understanding Regulatory Affairs. Pharmaceutical Regulatory Affairs journal from OMICS Group is an open-access journal named Pharmaceutical Regulatory Affairs Open Access Journal which strives to release issues quarterly and is adamant to publish new findings related to the field of Regulatory Affairs.

High Impact List of Articles

Conference Proceedings

In vitro toxicity assessment of anthrax toxins for intracellular drug delivery
Ahmed Somaida
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
In vitro toxicity assessment of anthrax toxins for intracellular drug delivery
Ahmed Somaida
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
The judicialization of the applications submitted to ANVISA
Marcio Raposo de Almeida
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
The judicialization of the applications submitted to ANVISA
Marcio Raposo de Almeida
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Regulatory frame work for biosimilar monoclonal antibodies
K. Sreekanth Reddy
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Regulatory frame work for biosimilar monoclonal antibodies
K. Sreekanth Reddy
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Informed consent process, the bane of unethical clinical research
Augustine Onyeaghala
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Informed consent process, the bane of unethical clinical research
Augustine Onyeaghala
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Targeting aryl hydrocarbon receptor (AhR) to discover new pathways and drugs with anti-inflammatory properties to treat autoimmune diseases
Prakash Nagarkatti
Keynote Forum: Pharmaceutical Regulatory Affairs: Open Access
Targeting aryl hydrocarbon receptor (AhR) to discover new pathways and drugs with anti-inflammatory properties to treat autoimmune diseases
Prakash Nagarkatti
Keynote Forum: Pharmaceutical Regulatory Affairs: Open Access

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals